CDSCO panel nod to Zydus antibodies cocktail trials to treat COVID Ruchika Sharma5 Jun 2021 1:03 PM ISTZydus said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) can emerge as one of the main...
Zydus Cadila gets USFDA nod for lung cancer drug Osimertinib Ruchika Sharma4 Jun 2021 3:44 PM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received tentative approval from the United States Food &...
Zydus Cadila gets USFDA nod to Fluphenazine Hydrochloride Tablets Ruchika Sharma30 May 2021 9:30 AM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Fluphenazine...
Zydus Cadila introduces scratch code in critical drug packs, starts with Remdac, Virafin Ruchika Sharma29 May 2021 12:55 PM ISTAhmedabad: Pharma major, Zydus Cadila, has recently announced that the company has introduced a new feature in the packaging of its critical drugs to...
Zydus Cadila seeks DCGI nod for clinical trials of monoclonal antibodies cocktail that neutralises COVID infection Ruchika Sharma27 May 2021 11:30 AM ISTZRC-3308 is a cocktail of two monoclonal antibodies targeting two unique epitopes on the spike protein of SARS-COV-2.
Zydus Cadila, TLC collaborate for AmphoTLC to treat Black Fungus in India Ruchika Sharma26 May 2021 6:16 PM ISTAmphoTLC is a liposomal amphotericin B injection indicated for severe systemic fungal infections such as mucormycosis.
Zydus Cadila launches breast cancer drug Ujvira Ruchika Sharma24 May 2021 10:00 AM ISTIn a step that can significantly reduce treatment cost by almost 80%, the drug is being offered at Rs. 32495 for a 100 mg vial.
Zydus Cadila COVID vaccine ZyCoV-D expected to hit market by June: Report Medical Dialogues Team16 May 2021 10:30 AM ISTAhmedabad: With a goal of producing 240 million doses per year, Zydus Cadila's ZyCoV-D, a second indigenous covid vaccine, is scheduled to reach the...
Zydus Cadila single dose COVID drug Virafin priced at Rs 11,995 per dose Medical Dialogues Team12 May 2021 5:18 PM ISTNew Delhi: Zydus Cadila's price fixation of its single-dose COVID drug Virafin at Rs 11,995 per dose claiming that it can cut oxygen dependency in...
Cadila Healthcare arm to sell animal health business for Rs 2921 crores Ruchika Sharma12 May 2021 3:24 PM ISTAhmedabad: A wholly-owned subsidiary of Cadila Healthcare Ltd, Zydus Animal Health and Investments Ltd (ZAHL) has entered into an agreement to sell...
Delhi HC asks CDSCO, Cipla to reply on PIL seeking to allow all Remdesivir makers to sell in domestic market Ruchika Sharma4 May 2021 3:24 PM ISTThe petition has also said that huge stocks of the medicine are lying at the ports for being exported and the same can be sold in the domestic market.
NPPA Panel suggests Price Of Cadila Healthcare Dexamethasone in 5 strengths Medical Dialogues Team28 April 2021 7:01 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of each uncoated tablet containing...
